| scholarly article | Q13442814 |
| P2093 | author name string | M Kaminska | |
| P B Mullan | |||
| Z D'Costa | |||
| N E Buckley | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene | Q24294911 | ||
| S100 proteins regulate the interaction of Hsp90 with Cyclophilin 40 and FKBP52 through their tetratricopeptide repeats | Q24301261 | ||
| A Pin1/mutant p53 axis promotes aggressiveness in breast cancer | Q24312083 | ||
| A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis | Q24312492 | ||
| Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation | Q24313442 | ||
| Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. | Q24535931 | ||
| Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment | Q24562633 | ||
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Intracellular and extracellular roles of S100 proteins | Q28184555 | ||
| Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
| Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization | Q28212970 | ||
| X chromosomal abnormalities in basal-like human breast cancer | Q28296876 | ||
| Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
| Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies | Q29617680 | ||
| Expression of calcium-binding protein S100A2 in breast lesions | Q30961562 | ||
| Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay | Q33622653 | ||
| The role of mutant p53 in human cancer | Q34153014 | ||
| Polyubiquitination of p53 by a ubiquitin ligase activity of p300. | Q34190044 | ||
| Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions | Q34437144 | ||
| Detection of the p53 response in zebrafish embryos using new monoclonal antibodies | Q34660684 | ||
| BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation | Q36187310 | ||
| The role of BRCA1 in transcriptional regulation and cell cycle control | Q36602565 | ||
| The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss | Q36649149 | ||
| BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers | Q37224721 | ||
| Hsp90, an unlikely ally in the war on cancer | Q37274497 | ||
| 17 AAG for HSP90 inhibition in cancer--from bench to bedside | Q37550778 | ||
| Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. | Q38621771 | ||
| Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein) | Q39205717 | ||
| BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers | Q39436579 | ||
| Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. | Q40052411 | ||
| A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. | Q40198186 | ||
| Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. | Q40243783 | ||
| An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer. | Q40297038 | ||
| The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. | Q40412703 | ||
| The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosis | Q40412826 | ||
| The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation | Q40418287 | ||
| A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors | Q40631570 | ||
| Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain | Q42185907 | ||
| Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin | Q42450706 | ||
| The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer | Q42484627 | ||
| HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. | Q45387477 | ||
| Chaperone-dependent stabilization and degradation of p53 mutants | Q46788559 | ||
| S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. | Q52027067 | ||
| Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. | Q52561781 | ||
| Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. | Q52564601 | ||
| Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. | Q53360582 | ||
| Immunohistochemical localization of the Ca2+binding S100 proteins in normal human skin and melanocytic lesions | Q56016553 | ||
| Gene-Expression Profiles in Hereditary Breast Cancer | Q57240053 | ||
| Stabilization of the MDM2 oncoprotein by mutant p53 | Q64380171 | ||
| The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association | Q73171130 | ||
| Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas | Q74156976 | ||
| Transcriptional activation of the human S100A2 promoter by wild-type p53 | Q74643574 | ||
| Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53 | Q84696189 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | e1070 | |
| P577 | publication date | 2014-02-20 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability | |
| P478 | volume | 5 |
| Q38788928 | A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer |
| Q38424946 | Epigenetic silencing of S100A2 in bladder and head and neck cancers |
| Q35793756 | Low spinophilin expression enhances aggressive biological behavior of breast cancer. |
| Q90671019 | Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer |
| Q60044321 | Prognostic values of S100 family members in ovarian cancer patients |
| Q58701866 | Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer |
| Q36182254 | TAp73 transcriptionally represses BNIP3 expression. |
| Q42016261 | The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain |
Search more.